Global Kidney Academy

The Global Kidney Academy (GKA) is an educational program for physicians and other healthcare professionals involved in nephrology.

[Global Kidney Academy @GKA_CME]

How do you help patients with IgA nephropathy move beyond fear of kidney failure and toward informed decision-making? Explore practical communication strategies for discussing prognosis, treatment options, and patient priorities in #IgAN: https://t.co/QGVu2SXCj2 #Nephrology

[Global Kidney Academy @GKA_CME]

CKD-associated pruritus is more than dry skin alone. Explore the roles of inflammation, neuropathy, uremic toxins, and opioid receptor imbalance in CKD-aP pathophysiology: https://t.co/JPMkqtX7vh

[Global Kidney Academy @GKA_CME]

What role does the complement pathway play in ANCA-associated vasculitis? Explore how C5a-mediated neutrophil activation contributes to inflammation, vascular injury, and kidney damage in AAV: https://t.co/O3Awxi7vZg #AAV #Nephrology

[Global Kidney Academy @GKA_CME]

Proteinuria below 1 g/day may still place patients with IgA nephropathy at risk for kidney failure. How are the 2025 #KDIGO guidelines reshaping treatment goals? Hear experts discuss earlier intervention and updated proteinuria targets: https://t.co/bYR0VthO4m
#Nephrology #IgAN

[Global Kidney Academy @GKA_CME]

Today is #IgANAwarenessDay! Take a deeper look at IgA nephropathy through expert-led programs exploring KDIGO recommendations, proteinuria reduction strategies, shared decision-making, and more: https://t.co/JDH14kOqnZ

#Nephrology #IgAN #KidneyHealth

[Global Kidney Academy @GKA_CME]

How do you manage #hyperkalemia without compromising guideline-directed medical therapy in #heartfailure?

A recent case highlights the challenge: stopping MRAs may normalize potassium but can worsen HF symptoms. Learn how potassium binders can help: https://t.co/dXVkwnN9wb

[Global Kidney Academy @GKA_CME]

Are antihistamines addressing the root cause of itch in CKD-aP? Emerging evidence shows CKD-associated pruritus is driven by non-histaminergic pathways, raising questions about traditional approaches. Explore the evolving science: https://t.co/IUAY7CZyAc
#Nephrology #CKDaP

[Global Kidney Academy @GKA_CME]

Beyond dermatologic manifestations, CKD-aP contributes to a cascade of symptoms affecting sleep quality, mental health, and daily functioning. Recognizing these interconnected effects is critical in clinical practice. Learn more: https://t.co/r2mSKXKVWZ #Nephrology

[Global Kidney Academy @GKA_CME]

How do you guide patients with IgA nephropathy through complex treatment decisions?

This CE activity explores shared decision-making, risk communication, and aligning care with patient priorities: https://t.co/CvvdBE5g35

#IgAN #Nephrology #CME

[Global Kidney Academy @GKA_CME]

How often does hyperkalemia limit your ability to optimize RAAS inhibitors?

This case-based discussion breaks down practical strategies to manage risk while maintaining guideline-directed medical therapy: https://t.co/183BBDQKz0

#Hyperkalemia #CardioRenal #MedEd

[Global Kidney Academy @GKA_CME]

#NationalKidneyMonth wraps up, but CKD-aP still deserves attention. This CME activity reviews the mechanisms behind CKD-associated pruritus, new European S2k guidelines, KALM study biomarker findings, and more: https://t.co/w9qvwfJSqH #Nephrology #MedicalEducation

[Global Kidney Academy @GKA_CME]

March is #NationalKidneyMonth.

This CME activity features Professor Jonathan Barratt in a real patient interaction, covering the Oxford MEST-C score, emerging treatment options, and practical shared decision-making in #IgAN care: https://t.co/nCI6TY2qLG #Nephrology #MedEd

[Global Kidney Academy @GKA_CME]

#NationalKidneyMonth continues. #Hyperkalemia complicates GDMT optimization in patients with #CKD and heart failure, yet potassium binder use remains low in clinical practice. Review KDIGO guidance, and examine emerging data: https://t.co/RcEusIwcXV
#Nephrology #MedicalEducation

[Global Kidney Academy @GKA_CME]

Does CKD-aP require ongoing treatment? Clinical experience across Europe suggests itch may return after dose reduction or discontinuation. Review long-term management insights this #WorldKidneyDay2026: https://t.co/eigmG1iXye #NationalKidneyMonth #OurKidneysOurPlanet

[Global Kidney Academy @GKA_CME]

In recognition of National Kidney Month, tune in to this expert discussion on the epidemiology, pathophysiology, clinical burden, and management of CKD-aP: https://t.co/H5o7Vpyciz #CKDaP #NationalKidneyMonth #OurKidneysOurPlanet #KidneyHealthForAll

[Global Kidney Academy @GKA_CME]

On #RareDiseaseDay, we recognize #IgAnephropathy (IgAN). Drs. Jonathan Barratt and Sydney Tang review updated guidelines and real-world data on combination therapy with a dual endothelin–angiotensin receptor antagonist and SGLT2 inhibitors: https://t.co/NLYJzGaR7K
#Nephrology

[Global Kidney Academy @GKA_CME]

Over 30% of patients on hemodialysis experience moderate to severe CKD-associated pruritus. Are we recognizing it in practice? Review the prevalence and clinical impact of this condition: https://t.co/1o0S2YOyjf #Nephrology #CKD #Dialysis

[Global Kidney Academy @GKA_CME]

A complex patient case highlights the overlap between #CKD, #diabetes, and #heartfailure, and the challenge of adhering to guideline therapy when potassium levels rise. Check out the full discussion for clinical context and expert insights: https://t.co/VJbybN3xIO #MedEd

[Global Kidney Academy @GKA_CME]

CKD-associated pruritus is often underrecognized, yet it has a significant impact on patients receiving hemodialysis. How can clinicians consistently assess itch severity and its effect on quality of life in everyday practice? Hear from leading experts: https://t.co/bhCGfwikFV

[Global Kidney Academy @GKA_CME]

Hear experts discuss current guideline recommendations for managing iron deficiency in heart failure, including when to use IV iron: https://t.co/2hWXShnjsZ #Cardiology #Nephrology #HeartFailure